Cargando…
Crosslinking of CD38 Receptors Triggers Apoptosis of Malignant B Cells
Recently, we designed an inventive paradigm in nanomedicine—drug-free macromolecular therapeutics (DFMT). The ability of DFMT to induce apoptosis is based on biorecognition at cell surface, and crosslinking of receptors without the participation of low molecular weight drugs. The system is composed...
Autores principales: | Gambles, M. Tommy, Li, Jiahui, Wang, Jiawei, Sborov, Douglas, Yang, Jiyuan, Kopeček, Jindřich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348492/ https://www.ncbi.nlm.nih.gov/pubmed/34361811 http://dx.doi.org/10.3390/molecules26154658 |
Ejemplares similares
-
A Two-Step Pretargeted Nanotherapy for CD20 Crosslinking May Achieve Superior Anti-Lymphoma Efficacy to Rituximab
por: Chu, Te-Wei, et al.
Publicado: (2015) -
Bone-Targeted Acid-Sensitive Doxorubicin Conjugate
Micelles as Potential Osteosarcoma Therapeutics
por: Low, Stewart A., et al.
Publicado: (2014) -
Broadening
and Enhancing Functions of Antibodies by
Self-Assembling Multimerization at Cell Surface
por: Li, Lian, et al.
Publicado: (2019) -
Apoptosis of cancer cells is triggered by selective crosslinking and inhibition of receptor tyrosine kinases
por: Wang, Kaidi, et al.
Publicado: (2019) -
Extensive crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent apoptosis in human lymphoma cells
por: Chang, Chien-Hsing, et al.
Publicado: (2014)